Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

PCR genotyping in cre-loxP mice can be inaccurate due to unintended gene deletions in non-target tissues.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Phospholipids help plant proteins move by regulating receptor interactions.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

CRABP2 helps increase the growth of cells important for hair growth by activating a specific growth pathway.

Cadd4 effectively reduces cholesterol levels without side effects.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

PRP preparation partially activates platelets, causing varied growth factor release.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Too much parathyroid hormone-related protein in skin disrupts hair growth in mice.

PADI4 enzyme slows down cell growth in developing hair follicles.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

PDGF signaling is crucial for maintaining fat stem cells in the skin, and its level of activation can either preserve these cells or cause fibrosis.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

PTHrP is higher in certain dog tumors and may act as a local growth factor.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

FLRG and follistatin have different roles in wound healing.